1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow niraparib: new trials by email Literature Review of niraparib trials Research Report on niraparib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment Niraparib, Dostarlimab, Pegylated liposomal doxorubicin - Ovarian Cancer | Phase 3 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 427 | 2020-12-01 | 2021-08-27 |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)
Italy (1)